Stem Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STMH research report →
Price Chart
About the company
Stem Holdings, Inc. operates as a fully integrated enterprise within the cannabis and technology sectors. Its core activities involve the cultivation, production, distribution, and sale of both cannabis and cannabis-derived products.
- CEO
- Matthew J. Cohen
- IPO
- 2021
- Employees
- 75
- HQ
- Boca Raton, FL, US
Get TickerSpark's AI analysis on STMH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $67
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.35
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -274.81%
- ROIC
- -26.63%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $0-100.0%
- Op Income
- $-3,747,000
- Net Income
- $-19,018,000-9.5%
- EPS
- $-5.92+11.9%
- OCF Growth
- +80.9%
- FCF Growth
- +81.5%
- 52W High
- $0.03
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.91
- RSI (14)
- 2
- Avg Volume
- 30
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Stem Holdings reported record fiscal Q3 2021 revenue growth driven by delivery and retail expansion, while margin pressure from a reclassification weighed on reported gross margin.· August 17, 2021
- Gross revenue rose to $12.4 million, up 104% from $6.1 million a year ago.
- Reported gross margin was 14%, but management said it would have been 41.8% without a reclassification from SG&A to COGS tied to the Driven delivery business.
- Operations momentum was strong in delivery and customer acquisition, including 78,455 deliveries in California and 3,850 new customers added in the quarter.
- Management reiterated a roadmap built around delivery expansion, retail growth, branded products, and accretive M&A.
- The company still expects $75 million of gross revenue for calendar 2021, though management said timing has shifted later in the year.
Fiscal third quarter 2021 gross revenue was $12.4 million, up $6.3 million, or 104%, from $6.1 million in the same quarter of 2020. Reported gross margin was 14%, and management said it would have been 41.8% for the quarter without the reclassification of expenses from SG&A to COGS related to the recent Driven cannabis delivery business acquisition. Management said the quarter included 57,603 transactions, 78,455 deliveries in California and nearly 1,000 in Oregon, plus 3,850 new customers and a $66 average order rate. Looking ahead, management said it still believes it will achieve $75 million of gross revenue in calendar 2021, but that the timing is likely to be slightly delayed as technology integration, Oregon launch timing, and other growth initiatives roll through.
CEO Adam Berk framed the quarter as validation of the company’s vertically integrated, farm-to-home strategy and said the business is building toward becoming a large publicly traded cannabis e-commerce and delivery platform. His tone was optimistic and expansive, emphasizing five paths to profitability, including delivery expansion, partnerships, branded products, and M&A. He repeatedly pointed to Oregon, Michigan, Georgia, and potential East Coast opportunities as future growth drivers, while stressing that technology integration and platform quality were essential to retention and long-term scale.
No separate CFO prepared remarks were provided on the call, so financial commentary came from the CEO. He explained that the 14% reported gross margin was distorted by a reclassification of delivery-related labor from SG&A to COGS, and said the company should see margin improvement from productivity, better purchasing, and product assortment. He also said the company does not need capital right now, but will remain opportunistic if growth or M&A opportunities arise.
Analyst Joe Gomes asked why net revenue was relatively flat sequentially despite strong year-over-year growth; management attributed that to normal summer seasonality, intensified by travel out of West Coast markets, and said new customer acquisition helped offset the decline. He also pressed on gross margin, and management said the reported 14% should improve as delivery labor classification normalizes and as sourcing and productivity gains flow through. Later, Joe asked about the beverage opportunity and capital needs; management said the company is pursuing a syrup-based product first, expects it to launch in Oregon by year-end, and said no near-term capital raise is needed.
The bull case from this call is that Stem is still showing strong top-line growth, with revenue more than doubling year over year and delivery/customer metrics moving in the right direction. Management sounded confident that technology, new markets, and branded products can drive both scale and better margins over time, while the company says it remains on track for $75 million of gross revenue in 2021, albeit later than originally expected.
The main bear case is that sequential growth was not yet accelerating, with management blaming seasonality, travel, and delayed launches. Reported gross margin looked weak at 14%, and while management said it was distorted, the company still faces integration complexity, staffing pressure, and execution risk across multiple new markets and product launches. The $75 million revenue goal was not abandoned, but management explicitly said it has been pushed back in timing.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 100.0%
- Shares Outstanding
- 6.67M
- Float Shares
- 6.67M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 23 | Rai Rajiv | other | 5,000,000 |
| Jul 19, 22 | Rai Rajiv | other | 162,500 |
| Dec 1, 22 | Rai Rajiv | other | 162,500 |
| Sep 30, 22 | Rai Rajiv | other | 2,169,853 |
| Apr 5, 23 | COHEN MATTHEW | other | 10,000,000 |
| Apr 21, 22 | COHEN MATTHEW | other | 359,961 |
| Apr 21, 22 | COHEN MATTHEW | other | 1,000,000 |
| Mar 30, 22 | COHEN MATTHEW | other | 0 |
| Mar 30, 22 | COHEN MATTHEW | other | 0 |
| Oct 1, 19 | Snider Lindy L | other | 159,044 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our STMH coverage
Recent articles, reports, and earnings notes.
No research on STMH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate STMH report →CSE Bulletin: Delist - Stem Holdings Inc. (STEM)
newsfilecorp.com · Sep 3
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
globenewswire.com · Sep 12
Cell Culture Market to Reach USD 44,593.1 million by 2034 amid Growing Demand for Biopharmaceuticals and Advances in Stem Cell Culture Techniques | Future Market Insights, Inc.
globenewswire.com · Aug 8
Naples Soap Company to Integrate Revolutionary NASA Stem Cell Technology into its New Skincare Line
businesswire.com · Jul 31
Automotive Valve Stem Seal Market Valuation to Reach USD 866.5 Million by 2034, Driven by Continued Growth in Automotive Industry and Technological Advancements | Future Market Insights Inc.
globenewswire.com · Jul 4
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
globenewswire.com · Jun 11
City of Hope Awarded $5.4 Million CIRM Grant to Create a Stem Cell Laboratory and Expand Access to State-of-the-Art Disease Models and Technology Among a Diverse Scientific Community
https://www.businesswire.com · May 20
CSE Bulletin: Suspension - Stem Holdings Inc. (STEM)
newsfilecorp.com · Mar 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.